Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 13, 2016 8:38 AM ET


Company Overview of Endonovo Therapeutics, Inc.

Executive Profile

Randolph M. Johnson Ph.D.

Chief Development Officer and Executive Vice President of Clinical Development, Endonovo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 5 different industries.



Dr. Randolph M. Johnson, Ph.D., has been Chief Development Officer and Executive Vice President of Clinical Development at Endonovo Therapeutics, Inc. since December 2, 2014. Dr. Johnson has been Chief Development Officer and Executive Vice President of Preclinical Development at Cortexyme, Inc. since July 2015. He served as Chief of Technology Development and Vice President of Research at KAI Pharmaceuticals, Inc. He served as President and Chief Executive Officer of ...

Corporate Headquarters

6320 Canoga Avenue
Woodland Hills, California 91367

United States

Phone: 800-489-4774
Fax: 818-230-9899

Board Members Memberships

There is no Board Members Memberships data available.


California State University, Long Beach
California State University, Long Beach
University of South Carolina School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Endonovo Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at